TABLE 63, [Incremental cost-effectiveness for the base...]. - Automated imaging technologies for the diagnosis of glaucoma: a comparative diagnostic study for the evaluation of the diagnostic accuracy, performance as triage tests and cost-effectiveness (GATE study)

NHS Reference Cost (£)	Intervention	Cost (£)	QALYs	ICER
10	GDx	2841	19.7701	–
OCT	2967	19.7746	27,812
HRT-MRA	3001	19.7771	13,807
HRT-GPS	3011	19.7771	Dominated^a
Current practice	3084	19.7780	98,231
13	GDx	2856	19.7701	–
OCT	2982	19.7746	27,784
HRT-MRA	3016	19.7771	13,780
HRT-GPS	3026	19.7771	Dominated^a
Current practice	3084	19.7780	80,605
16	GDx	2872	19.7701	–
OCT	2996	19.7746	27,757
HRT-MRA	3031	19.7771	13,754
HRT-GPS	3040	19.7771	Dominated^a
Current practice	3084	19.7780	62,979
19	GDx	2887	19.7701	–
OCT	3011	19.7746	27,729
HRT-MRA	3046	19.7771	13,727
HRT-GPS	3055	19.7771	Dominated^a
Current practice	3084	19.7780	45,353
22	GDx	2902	19.7701	–
OCT	3026	19.7746	27,701
HRT-MRA	3060	19.7771	13,700
HRT-GPS	3070	19.7771	Dominated^a
Current practice	3084	19.7780	27,727
25	GDx	2917	19.7701	–
OCT	3041	19.7746	27,673
HRT-MRA	3075	19.7771	13,673
Current practice	3084	19.7780	10,101
HRT-GPS	3085	19.7771	Dominated^a
28	GDx	2932	19.7701	–
OCT	3056	19.7746	27,646
Current practice	3084	19.7780	8313
HRT-MRA	3090	19.7771	Dominated^a
HRT-GPS	3100	19.7771	Dominated^a
31	GDx	2947	19.7701	–
OCT	3071	19.7746	27,618
Current practice	3084	19.7780	3853
HRT-MRA	3105	19.7771	Dominated^a
HRT-GPS	3115	19.7771	Dominated^a
34	GDx	2962	19.7701	–
Current practice	3084	19.7780	15,579
OCT	3086	19.7746	Dominated^a
HRT-MRA	3120	19.7771	Dominated^a
HRT-GPS	3129	19.7771	Dominated^a
37	GDx	2977	19.7701	–
Current practice	3084	19.7780	13,663
OCT	3101	19.7746	Dominated^a
HRT-MRA	3135	19.7771	Dominated^a
HRT-GPS	3144	19.7771	Dominated^a
40	GDx	2992	19.7701	–
Current practice	3084	19.7780	11,747
OCT	3116	19.7746	Dominated^a
HRT-MRA	3149	19.7771	Dominated^a
HRT-GPS	3159	19.7771	Dominated^a
43	GDx	3007	19.7701	–
Current practice	3084	19.7780	9831
OCT	3130	19.7746	Dominated^a
HRT-MRA	3164	19.7771	Dominated^a
HRT-GPS	3174	19.7771	Dominated^a
46	GDx	3022	19.7701	–
Current practice	3084	19.7780	7315
OCT	3145	19.7746	Dominated^a
HRT-MRA	3179	19.7771	Dominated^a
HRT-GPS	3189	19.7771	Dominated^a
49	GDx	3037	19.7701	–
Current practice	3084	19.7780	5999
OCT	3160	19.7746	Dominated^a
HRT-MRA	3194	19.7771	Dominated^a
HRT-GPS	3204	19.7771	Dominated^a
52	GDx	3052	19.7701	–
Current practice	3084	19.7780	4083
OCT	3175	19.7746	Dominated^a
HRT-MRA	3209	19.7771	Dominated^a
HRT-GPS	3218	19.7771	Dominated^a
55	GDx	3067	19.7701	–
Current practice	3084	19.7780	2168
OCT	3190	19.7746	Dominated^a
HRT-MRA	3224	19.7771	Dominated^a
HRT-GPS	3233	19.7771	Dominated^a
58	GDx	3082	19.7701	–
Current practice	3084	19.7780	252
OCT	3205	19.7746	Dominated^a
HRT-MRA	3238	19.7771	Dominated^a
HRT-GPS	3248	19.7771	Dominated^a
61	Current practice	3084	19.7780	–
GDx	3097	19.7701	Dominated^a
OCT	3220	19.7746	Dominated^a
HRT-MRA	3253	19.7771	Dominated^a
HRT-GPS	3263	19.7771	Dominated^a
64	Current practice	3084	19.7780	–
GDx	3112	19.7701	Dominated^a
OCT	3235	19.7746	Dominated^a
HRT-MRA	3268	19.7771	Dominated^a
HRT-GPS	3278	19.7771	Dominated^a
67	Current practice	3084	19.7780	–
GDx	3127	19.7701	Dominated^a
OCT	3250	19.7746	Dominated^a
HRT-MRA	3283	19.7771	Dominated^a
HRT-GPS	3292	19.7771	Dominated^a
70	Current practice	3084	19.7780	–
GDx	3142	19.7701	Dominated^a
OCT	3265	19.7746	Dominated^a
HRT-MRA	3298	19.7771	Dominated^a
HRT-GPS	3307	19.7771	Dominated^a
73	Current practice	3084	19.7780	–
GDx	3157	19.7701	Dominated^a
OCT	3279	19.7746	Dominated^a
HRT-MRA	3313	19.7771	Dominated^a
HRT-GPS	3322	19.7771	Dominated^a
76	Current practice	3084	19.7780	–
GDx	3172	19.7701	Dominated^a
OCT	3294	19.7746	Dominated^a
HRT-MRA	3327	19.7771	Dominated^a
HRT-GPS	3337	19.7771	Dominated^a
79	Current practice	3084	19.7780	–
GDx	3187	19.7701	Dominated^a
OCT	3309	19.7746	Dominated^a
HRT-MRA	3342	19.7771	Dominated^a
HRT-GPS	3352	19.7771	Dominated^a
82	Current practice	3084	19.7780	–
GDx	3202	19.7701	Dominated^a
OCT	3324	19.7746	Dominated^a
HRT-MRA	3357	19.7771	Dominated^a
HRT-GPS	3367	19.7771	Dominated^a
85	Current practice	3084	19.7780	–
GDx	3217	19.7701	Dominated^a
OCT	3339	19.7746	Dominated^a
HRT-MRA	3372	19.7771	Dominated^a
HRT-GPS	3381	19.7771	Dominated^a

NHS Reference Cost (£)

Intervention

Cost (£)

QALYs

ICER

GDx

2841

19.7701

–

OCT

2967

19.7746

27,812

HRT-MRA

3001

19.7771

13,807

HRT-GPS

3011

19.7771

Dominated^a

Current practice

3084

19.7780

98,231

GDx

2856

19.7701

–

OCT

2982

19.7746

27,784

HRT-MRA

3016

19.7771

13,780

HRT-GPS

3026

19.7771

Dominated^a

Current practice

3084

19.7780

80,605

GDx

2872

19.7701

–

OCT

2996

19.7746

27,757

HRT-MRA

3031

19.7771

13,754

HRT-GPS

3040

19.7771

Dominated^a

Current practice

3084

19.7780

62,979

GDx

2887

19.7701

–

OCT

3011

19.7746

27,729

HRT-MRA

3046

19.7771

13,727

HRT-GPS

3055

19.7771

Dominated^a

Current practice

3084

19.7780

45,353

GDx

2902

19.7701

–

OCT

3026

19.7746

27,701

HRT-MRA

3060

19.7771

13,700

HRT-GPS

3070

19.7771

Dominated^a

Current practice

3084

19.7780

27,727

GDx

2917

19.7701

–

OCT

3041

19.7746

27,673

HRT-MRA

3075

19.7771

13,673

Current practice

3084

19.7780

10,101

HRT-GPS

3085

19.7771

Dominated^a

GDx

2932

19.7701

–

OCT

3056

19.7746

27,646

Current practice

3084

19.7780

8313

HRT-MRA

3090

19.7771

Dominated^a

HRT-GPS

3100

19.7771

Dominated^a

GDx

2947

19.7701

–

OCT

3071

19.7746

27,618

Current practice

3084

19.7780

3853

HRT-MRA

3105

19.7771

Dominated^a

HRT-GPS

3115

19.7771

Dominated^a

GDx

2962

19.7701

–

Current practice

3084

19.7780

15,579

OCT

3086

19.7746

Dominated^a

HRT-MRA

3120

19.7771

Dominated^a

HRT-GPS

3129

19.7771

Dominated^a

GDx

2977

19.7701

–

Current practice

3084

19.7780

13,663

OCT

3101

19.7746

Dominated^a

HRT-MRA

3135

19.7771

Dominated^a

HRT-GPS

3144

19.7771

Dominated^a

GDx

2992

19.7701

–

Current practice

3084

19.7780

11,747

OCT

3116

19.7746

Dominated^a

HRT-MRA

3149

19.7771

Dominated^a

HRT-GPS

3159

19.7771

Dominated^a

GDx

3007

19.7701

–

Current practice

3084

19.7780

9831

OCT

3130

19.7746

Dominated^a

HRT-MRA

3164

19.7771

Dominated^a

HRT-GPS

3174

19.7771

Dominated^a

GDx

3022

19.7701

–

Current practice

3084

19.7780

7315

OCT

3145

19.7746

Dominated^a

HRT-MRA

3179

19.7771

Dominated^a

HRT-GPS

3189

19.7771

Dominated^a

GDx

3037

19.7701

–

Current practice

3084

19.7780

5999

OCT

3160

19.7746

Dominated^a

HRT-MRA

3194

19.7771

Dominated^a

HRT-GPS

3204

19.7771

Dominated^a

GDx

3052

19.7701

–

Current practice

3084

19.7780

4083

OCT

3175

19.7746

Dominated^a

HRT-MRA

3209

19.7771

Dominated^a

HRT-GPS

3218

19.7771

Dominated^a

GDx

3067

19.7701

–

Current practice

3084

19.7780

2168

OCT

3190

19.7746

Dominated^a

HRT-MRA

3224

19.7771

Dominated^a

HRT-GPS

3233

19.7771

Dominated^a

GDx

3082

19.7701

–

Current practice

3084

19.7780

252

OCT

3205

19.7746

Dominated^a

HRT-MRA

3238

19.7771

Dominated^a

HRT-GPS

3248

19.7771

Dominated^a

Current practice

3084

19.7780

–

GDx

3097

19.7701

Dominated^a

OCT

3220

19.7746

Dominated^a

HRT-MRA

3253

19.7771

Dominated^a

HRT-GPS

3263

19.7771

Dominated^a

Current practice

3084

19.7780

–

GDx

3112

19.7701

Dominated^a

OCT

3235

19.7746

Dominated^a

HRT-MRA

3268

19.7771

Dominated^a

HRT-GPS

3278

19.7771

Dominated^a

Current practice

3084

19.7780

–

GDx

3127

19.7701

Dominated^a

OCT

3250

19.7746

Dominated^a

HRT-MRA

3283

19.7771

Dominated^a

HRT-GPS

3292

19.7771

Dominated^a

Current practice

3084

19.7780

–

GDx

3142

19.7701

Dominated^a

OCT

3265

19.7746

Dominated^a

HRT-MRA

3298

19.7771

Dominated^a

HRT-GPS

3307

19.7771

Dominated^a

Current practice

3084

19.7780

–

GDx

3157

19.7701

Dominated^a

OCT

3279

19.7746

Dominated^a

HRT-MRA

3313

19.7771

Dominated^a

HRT-GPS

3322

19.7771

Dominated^a

Current practice

3084

19.7780

–

GDx

3172

19.7701

Dominated^a

OCT

3294

19.7746

Dominated^a

HRT-MRA

3327

19.7771

Dominated^a

HRT-GPS

3337

19.7771

Dominated^a

Current practice

3084

19.7780

–

GDx

3187

19.7701

Dominated^a

OCT

3309

19.7746

Dominated^a

HRT-MRA

3342

19.7771

Dominated^a

HRT-GPS

3352

19.7771

Dominated^a

Current practice

3084

19.7780

–

GDx

3202

19.7701

Dominated^a

OCT

3324

19.7746

Dominated^a

HRT-MRA

3357

19.7771

Dominated^a

HRT-GPS

3367

19.7771

Dominated^a

Current practice

3084

19.7780

–

GDx

3217

19.7701

Dominated^a

OCT

3339

19.7746

Dominated^a

HRT-MRA

3372

19.7771

Dominated^a

HRT-GPS

3381

19.7771

Dominated^a

From: Appendix 7, Cost-effectiveness supplementary tables

Cover of Automated imaging technologies for the diagnosis of glaucoma: a comparative diagnostic study for the evaluation of the diagnostic accuracy, performance as triage tests and cost-effectiveness (GATE study)

Automated imaging technologies for the diagnosis of glaucoma: a comparative diagnostic study for the evaluation of the diagnostic accuracy, performance as triage tests and cost-effectiveness (GATE study).

Health Technology Assessment, No. 20.8.

Azuara-Blanco A, Banister K, Boachie C, et al.

Southampton (UK): NIHR Journals Library; 2016 Jan.

Copyright © Queen’s Printer and Controller of HMSO 2016. This work was produced by Azuara-Blanco et al. under the terms of a commissioning contract issued by the Secretary of State for Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK.

Included under terms of UK Non-commercial Government License.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.